Ryan K. Alexander

Ryan K. Alexander

Auto-generated profile, based on publicly available information

Ryan K. Alexander

Department of Molecular Metabolism, Division of Biological Sciences, Harvard TH Chan School of Public Health, Boston, United States

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in eLife
Verified
Journal Article
Open access
RARyan K Alexander
Ryan K Alexander
YLYae-Huei Liou
Yae-Huei Liou
NKNelson H Knudsen
Nelson H Knudsen
KSKyle A Starost
Kyle A Starost
CXChuanrui Xu
Chuanrui Xu
CLChih-Hao Lee
Chih-Hao Lee
Metabolic pathways and inflammatory processes are under circadian regulation. Rhythmic immune cell recruitment is known to impact infection outcomes, but whether the circadian clock modulates immunometabolism remains unclear. We find that the molecular clock Bmal1 is induced by inflammatory stimulants, including Ifn-γ/lipopolysaccharide (M1) and tumor-conditioned medium, to maintain mitochondrial metabolism under metabolically stressed conditions in mouse macrophages. Upon M1 stimulation, myeloid-specific Bmal1 knockout (M-BKO) renders macrophages unable to sustain mitochondrial function, enhancing succinate dehydrogenase (SDH)-mediated mitochondrial production of reactive oxygen species as well as Hif-1α-dependent metabolic reprogramming and inflammatory damage. In tumor-associated macrophages, aberrant Hif-1α activation and metabolic dysregulation by M-BKO contribute to an immunosuppressive tumor microenvironment. Consequently, M-BKO increases melanoma tumor burden, whereas administering the SDH inhibitor dimethyl malonate suppresses tumor growth. Therefore, Bmal1 functions as a metabolic checkpoint that integrates macrophage mitochondrial metabolism, redox homeostasis and effector functions. This Bmal1-Hif-1α regulatory loop may provide therapeutic opportunities for inflammatory diseases and immunotherapy.

30 April 2020 in Science
Verified
Journal Article
Closed access
PDF file
NKNelson H. Knudsen
Nelson H. Knudsen
KSKristopher J. Stanya
Kristopher J. Stanya
AHAlexander L. Hyde
Alexander L. Hyde
MCMayer M. Chalom
Mayer M. Chalom
RARyan K. Alexander
Ryan K. Alexander
CLChih-Hao Lee
Chih-Hao Lee
IL-13 hits the gym: Interleukin-13 (IL-13) is a cytokine secreted by T cells, innate lymphoid cells (ILC2s), and granulocytes. It acts as a central mediator in allergy and antihelminth defense with various effects. Knudsen et al. report a distinct role for IL-13 in exercise and metabolism (see the Perspective by Correia and Ruas). Mice subjected to endurance training showed increases in circulating IL-13, which correlated with ILC2 expansion in the muscles. By contrast, exercise-induced increases in muscle fatty acid utilization and mitochondrial biogenesis were erased when mice lacked IL-13. Activation of signaling pathways downstream of the muscle IL-13 receptor was key to this effect. Intramuscular injection of adenoviral IL-13 could recapitulate exercise-induced metabolic reprogramming. This signaling pathway may have evolved to combat the metabolic stresses of parasite infection. Science , this issue p. eaat3987 ; see also p. 470

8 April 2014 in Neurology
Verified
Journal Article
Closed access
BPBrett Parker
Brett Parker
RARyan Alexander
Ryan Alexander
NSNathalie Schnetz-Boutaud
Nathalie Schnetz-Boutaud
XWXingyao Wu
Xingyao Wu
MSMichael Shy
Michael Shy
JLJun Li
Jun Li